Remove 2020 Remove Life Science Remove Medicare
article thumbnail

Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Intravascular Imaging Platform

Digital Health Global

Launched in 2019, Vensana manages $550M in capital and is actively investing in development and commercial stage companies across the Medtech sector, including medical devices, diagnostics and data science, life science tools, digital health, and tech-enabled services. 1 Centers for Medicare & Medicaid Services (CMS).

article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

in the first quarter of 2020. The first chart from the Edelman health care update demonstrates that in most countries polled, health citizens’ trust in health care was buoyed in the first five months of 2020 (January through May): up 18 points in the U.S., Consumer health’s fall from 63% in 2019 to 51% in 2020.

BioTech 317
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act. In the case of Medicare Part D, the drug benefit, Chandra said, “If you’re sick enough to fall into the donut hole, you may have higher mortality.”

article thumbnail

Medical costs projected to increase 6% by 2020, says PwC

Henry Kotula

Between 2020 and 2027, retail drug spending under private health insurance is projected to increase at a rate of 3 percent to 6 percent a year as the impact of generics on spending plateaus, biosimilars continue to see slow uptake, and costly new therapies enter the market. WHAT’S THE IMPACT. One is that drug spending will grow faster.

article thumbnail

PurpleLab, Inc. Raises $40M in Funding from Primus Capital

Healthcare IT Today

Phil Molner, Managing Partner at Primus Capital, stated “Through its HealthNexus platform, PurpleLab has successfully organized and deployed real-world data to bring differentiated yet rapid commercial and clinical insights to the life sciences industry. About PurpleLab.

article thumbnail

Here are the major issues facing healthcare in 2021, according to PwC

Healthcare IT News - Telehealth

” For this report, PwC’s Health Research Institute surveyed 2,511 American consumers, 128 health plan executives, 153 healthcare provider organization executives, and 124 pharmaceutical and life sciences executives in August and September 2020. ” the report read. “Quite a bit, it turns out.

article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.

BioTech 270